arBtrage CAPITALIZING MARKETS checking… Sign in

Humacyte, Inc.

HUMA Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$1.35
▼ -9.4% Today
as of Jun 7, 07:17 ET
Last 30 days +59.20% Apr 28 → Jun 05
$0.77 $0.96 $1.16 $1.35 $1.54 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$1.49
High
$1.50
Low
$1.33
Volume
$6M
Avg Vol
$6M
Mkt Cap
$284M
P/E (TTM)
Beta
52w High
$2.93
52w Low
$0.55
Div Yield
Shares Out
$222M

Overview

52-week range
$0.55
$2.93
34% of range
Avg surprise (last 2)
+28.7%
Avg reaction (last 2)
+27.6%
100% positive
Latest IV / EM
187%
EM ±25.9% · $2 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.48$-0.38$-0.28$-0.19$-0.09 Actual $-0.22Actual $-0.25Actual $-0.29Actual $-0.48Actual $-0.33Actual $-0.10Est $-0.19Actual $-0.24Actual $-0.11Actual $-0.09Est $-0.10 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-57M$-32M$-8M$17M$41M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.09 $-0.10 +10.0% +10.0% +24.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.11 financials
Mon Jun 30, 2025Jun 2025 $-0.24 financials
Tue May 13, 2025Mar/2025 $-0.10 $-0.19 +47.4% +31.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.33 financials
Sun Jun 30, 2024Jun 2024 $-0.48 financials
Sun Mar 31, 2024Mar 2024 $-0.29 financials
Sat Sep 30, 2023Sep 2023 $-0.25 financials
Fri Jun 30, 2023Jun 2023 $-0.22 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$495,000$753,000$301,000$517,000$0$0
Cost of revenue$2M$260,000$213,000$147,000$0$0
Gross profit
Operating income$-29M$-24M$-30M$-23M$-30M$-29M
Net income$-18M$-18M$-38M$39M$-39M$-57M
EPS (diluted)$-0.09$-0.11$-0.24$0.28$-0.33$-0.48

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$49M$50M$19M$38M$63M$45M$21M$94M
Inventory$10M$14M$18M$11M$8M$0
Total current assets$64M$68M$41M$52M$74M$48M$23M$96M
Total assets$111M$116M$92M$139M$163M$138M$115M$138M
Long-term debt$36M$35M
Total liabilities$99M$113M$96M$135M$127M$191M$178M$167M
Total equity$12M$3M$-5M$4M$36M$-53M$-64M$-28M

Implied volatility — last 90 days

182%184%187%189%192% Jun 07 — IV 187% · EM ±25.9%

Sector peers